ATE468133T1 - Verwendung von g-csf als zusätzliche behandlung in die wiederherstellung von bindegewebe - Google Patents

Verwendung von g-csf als zusätzliche behandlung in die wiederherstellung von bindegewebe

Info

Publication number
ATE468133T1
ATE468133T1 AT02702463T AT02702463T ATE468133T1 AT E468133 T1 ATE468133 T1 AT E468133T1 AT 02702463 T AT02702463 T AT 02702463T AT 02702463 T AT02702463 T AT 02702463T AT E468133 T1 ATE468133 T1 AT E468133T1
Authority
AT
Austria
Prior art keywords
csf
medicament
treatment
factor
connective tissue
Prior art date
Application number
AT02702463T
Other languages
English (en)
Inventor
Didier Pourquier
Didier Moukoko
Original Assignee
Didier Pourquier
Didier Moukoko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Didier Pourquier, Didier Moukoko filed Critical Didier Pourquier
Application granted granted Critical
Publication of ATE468133T1 publication Critical patent/ATE468133T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02702463T 2001-02-22 2002-02-07 Verwendung von g-csf als zusätzliche behandlung in die wiederherstellung von bindegewebe ATE468133T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0102406A FR2820979B1 (fr) 2001-02-22 2001-02-22 Nouvelle application therapeutique du g-csf
PCT/FR2002/000480 WO2002066051A1 (fr) 2001-02-22 2002-02-07 Utilisation du g-csf comme traitement adjuvant dans la reconstruction de tissus conjonctifs

Publications (1)

Publication Number Publication Date
ATE468133T1 true ATE468133T1 (de) 2010-06-15

Family

ID=8860311

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02702463T ATE468133T1 (de) 2001-02-22 2002-02-07 Verwendung von g-csf als zusätzliche behandlung in die wiederherstellung von bindegewebe

Country Status (9)

Country Link
EP (1) EP1365795B1 (de)
AT (1) ATE468133T1 (de)
AU (1) AU2002235991A1 (de)
DE (1) DE60236411D1 (de)
DK (1) DK1365795T3 (de)
ES (1) ES2346044T3 (de)
FR (1) FR2820979B1 (de)
PT (1) PT1365795E (de)
WO (1) WO2002066051A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003263050A1 (en) * 2003-09-02 2005-04-21 Regenetech, Inc. Method of regenerating human tissue
JPWO2008020638A1 (ja) * 2006-08-15 2010-01-07 国立大学法人神戸大学 靭帯損傷治療剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61227526A (ja) 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
US4810643A (en) 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
WO1998051317A1 (en) * 1997-05-13 1998-11-19 Osiris Therapeutics, Inc. Osteoarthritis cartilage regeneration using human mesenchymal stem cells
PT1028737E (pt) * 1997-07-03 2007-07-11 Osiris Therapeutics Inc Células estaminais mesenquimatosas humanas de sangue periférico

Also Published As

Publication number Publication date
AU2002235991A1 (en) 2002-09-04
EP1365795B1 (de) 2010-05-19
ES2346044T3 (es) 2010-10-08
DE60236411D1 (de) 2010-07-01
FR2820979A1 (fr) 2002-08-23
WO2002066051A8 (fr) 2002-11-14
FR2820979B1 (fr) 2004-03-12
WO2002066051A1 (fr) 2002-08-29
EP1365795A1 (de) 2003-12-03
PT1365795E (pt) 2010-08-19
DK1365795T3 (da) 2010-09-13

Similar Documents

Publication Publication Date Title
DK1140212T3 (da) Målrettet anvendelse af radium 223 mod kalkholdigt væv til lettelse af smerter ved behandling af knoglekræft
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
BR9707153A (pt) Compostos biaromáticos composição farmacêutica composição cosmética e utilização de uma composição cosmética
PL323363A1 (en) Biaromatic propynyl or dienyl compounds
Liu et al. One-stage management of post-traumatic tibial infected nonunion using bone transport after debridement
BR9708297A (pt) Compostos composição farmacéutica cosmposição e uso de uma composição cosmética
MXPA03010628A (es) Analogos de vitamina d.
NO20071238L (no) Fremgangsmater for leging av skader ved human IL-18 administrering
NO980375L (no) Humant MP52 Arg protein
ATE468133T1 (de) Verwendung von g-csf als zusätzliche behandlung in die wiederherstellung von bindegewebe
EP1361905B8 (de) Verwendung von matrixprotein für gesteuerte geweberegenerationen
Baruah Accordion manoeuvre with ilizarov frame over nail in situ in a case of infected non-union of femur: discussion on strategies: a case report
UA43074A (uk) Спосіб лікування остеоартрозу
UA43073A (uk) Спосіб лікування остеоартрозу
Singh Use of MatriDerm®(skin substitute) and split skin graft in one stage in wound healing of exposed tibia without periosteum in two patients
AHMED et al. To evaluate functional outcome in patients with closed fracture shaft of humerus treated conservatively with coaptation splint
Noever et al. The free radial forearm flap for reconstruction of facial defects in noma patients
Edgardo Rodriguez et al. Ilizarov method of fixation for the management of pilon and distal tibial fractures in the compromised diabetic patient: A technique guide.
Scholl Dictionary of the Feet: Giving a Complete Definition of the Words and Terms Used in Anatomy, Physiology, Normal and Abnormal Conditions and Mechanical Treatment of the Human Foot, with Pronunciation
Ronald Belczyk et al. Monthly Archives: July 2008
DE50310383D1 (de) Humanes chondroosteomodulin (tig2), herstellung und verwendung zur behandlung oder diagnose von knochen- und knorpelerkrankungen, fettsucht sowie entzündlichen erkrankungen und hauterkrankungen
Lewis et al. Congenital Arteriovenous Malformations of the Upper Extremity. John M. Griffin
MD1268B2 (en) Method for surgical treatment of meta-physar fracture of children should bone distal part
Pennig Foreword| Injury-Volume 31, Supplement 1

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1365795

Country of ref document: EP